Related Experiment Videos
p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas
Svetlana Bolshakov1, Christopher M Walker, Sara S Strom
1Department of Immunology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA.
Summary
Investigating p53 mutations in basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) reveals UV radiation as a cause. However, specific mutations do not clearly predict tumor aggressiveness.
Area of Science:
- Dermatology
- Oncology
- Molecular Biology
Background:
- Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are common skin cancers.
- The p53 tumor suppressor gene plays a critical role in preventing cancer development.
- Understanding p53 mutations in different skin cancer subtypes is crucial for prognosis.
Purpose of the Study:
- To compare the p53 mutation spectrum in aggressive versus nonaggressive BCCs and SCCs.
- To determine if specific p53 mutations can predict tumor aggressiveness in these skin cancers.
Main Methods:
- Analysis of 342 tissue samples from patients with aggressive and nonaggressive BCCs and SCCs.
- Detection of p53 mutations using single-strand conformation polymorphism and nucleotide sequencing.
Main Results:
- p53 mutations were found in 66% of aggressive BCCs, 38% of nonaggressive BCCs, 35% of aggressive SCCs, and 50% of nonaggressive SCCs.
- UV signature mutations constituted approximately 71% of all detected p53 mutations.
- While differences in mutation frequency and type existed between aggressive and nonaggressive tumors, they were not definitive prognostic indicators.
Conclusions:
- UV radiation is implicated in the initiation of both aggressive and nonaggressive BCCs and SCCs through p53 mutations.
- Current p53 mutation analysis does not provide clear diagnostic or prognostic indicators for skin tumor aggressiveness.
- Other genetic alterations likely contribute to the aggressive nature of these skin cancers.